Vivimed Labs informs about revised statement of impact on audit qualifications & declaration

05 Jul 2023 Evaluate

Vivimed Labs has informed that it enclosed the statement on Impact of Audit Qualifications & Declaration for the Financial Year Ended March 31st, 2023, (Regulation 33 / 52 of the SEBI (LODR) (Amendment), Regulations, 2016).

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

7.00 -0.36 (-4.89%)
22-Jan-2026 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1622.00
Dr. Reddys Lab 1220.80
Cipla 1379.40
Zydus Lifesciences 884.00
Lupin 2176.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×